Together Pharma Ltd
TGPHF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $29 | $25 | $17 | $17 |
| - Cash | $4 | $5 | $5 | $6 |
| + Debt | $55 | $59 | $85 | $57 |
| Enterprise Value | $80 | $79 | $97 | $68 |
| Revenue | $91 | $31 | $12 | $11 |
| % Growth | 191.4% | 159.7% | 7.2% | – |
| Gross Profit | $35 | -$6 | -$2 | -$6 |
| % Margin | 38% | -18.9% | -18.1% | -52% |
| EBITDA | $28 | -$14 | -$6 | $21 |
| % Margin | 30.3% | -46% | -51% | 183.2% |
| Net Income | -$4 | -$34 | -$14 | $7 |
| % Margin | -4.7% | -107.4% | -114.6% | 63.7% |
| EPS Diluted | -0.49 | -4.11 | -2.01 | 1.24 |
| % Growth | 88.1% | -104.5% | -262.1% | – |
| Operating Cash Flow | $15 | -$14 | -$19 | -$10 |
| Capital Expenditures | -$1 | -$0 | -$2 | -$14 |
| Free Cash Flow | $14 | -$14 | -$20 | -$23 |